Romero-Cristóbal Mario, Díaz-Fontenla Fernando, Fernández-Yunquera Ainhoa, Caballero-Marcos Aranzazu, Conthe Andrés, Velasco Enrique, Pérez-Peña José, López-Baena José-Ángel, Rincón Diego, Bañares Rafael, Salcedo Magdalena
Liver Unit, Digestive Department, H.G.U. Gregorio Marañón, Madrid. Spain.
CIBEREHD. Instituto de Salud Carlos III, Madrid, Spain.
Transplant Direct. 2024 Jul 29;10(8):e1684. doi: 10.1097/TXD.0000000000001684. eCollection 2024 Aug.
Demographic analyses may reveal current patterns of change in the outcomes of rapidly developing medical procedures because they incorporate the period perspective.
We analyzed the changes in size, age structure, and hospitalizations in the population of liver transplantation (LT) survivors in our center during the last 30 y (n = 1114 patients) and generated projections, including life expectancy (LE), considering cohort and period effects. Life tables were used to project the complete LE (overall 1990-2020 experience), the cohort LE (according to the decade of surgery: 1990-2000, 2000-2010, and 2010-2020), and the period LE (current 2015-2020 experience).
The population of LT recipients in follow-up continued to experience progressive growth and aging since 1990 (492 patients [41.9% >65 y] in 2020), and the magnitude of these phenomena may double in the next 30 y. However, the number of admissions and days of admission has been decreasing. The complete LE at LT was 12.4 y, whereas the period LE was 15.8 y. The cohort LE (limited to 10 y) was 5.3, 6.3, and 7.3 y for the 1990-2000, 2000-2010, and 2010-2020 cohorts, respectively.
The target population of our medical care after LT is growing and aging. The prevalence of both of these phenomena is expected to increase in the coming years and is associated with a current improvement in LE. However, the hospitalization burden associated with LT survivors is declining. The period effect should be considered for generating up-to-date information on these current trends, which are crucial when designing health policies for LT survivors.
人口统计学分析可以揭示快速发展的医疗程序结果的当前变化模式,因为它们纳入了时期视角。
我们分析了本中心过去30年中肝移植(LT)幸存者人群的规模、年龄结构和住院情况的变化(n = 1114例患者),并考虑队列效应和时期效应生成了包括预期寿命(LE)在内的预测。生命表用于预测完整的预期寿命(1990 - 2020年总体经验)、队列预期寿命(根据手术年代:1990 - 2000年、2000 - 2010年和2010 - 2020年)以及时期预期寿命(2015 - 2020年当前经验)。
自1990年以来,接受随访的LT受者人群持续经历着渐进性增长和老龄化(2020年有492例患者[41.9%>65岁]),并且这些现象的规模在未来30年可能会翻倍。然而,入院次数和住院天数一直在减少。LT时的完整预期寿命为12.4年,而时期预期寿命为15.8年。1990 - 2000年、2000 - 2010年和2010 - 2020年队列的队列预期寿命(限于10年)分别为5.3年、6.3年和7.3年。
我们LT后医疗护理的目标人群在增长且老龄化。预计这两种现象的患病率在未来几年都会增加,并且与当前预期寿命的改善相关。然而,与LT幸存者相关的住院负担正在下降。在生成关于这些当前趋势的最新信息时应考虑时期效应,这在为LT幸存者设计卫生政策时至关重要。